BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/12/2024 10:04:17 AM | Browse: 150 | Download: 481
 |
Received |
|
2023-09-19 08:40 |
|
Peer-Review Started |
|
2023-09-19 08:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-05 06:20 |
|
Revised |
|
2023-12-15 11:28 |
|
Second Decision |
|
2024-01-27 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-01-27 04:43 |
|
Articles in Press |
|
2024-01-27 04:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-01-24 20:49 |
|
Typeset the Manuscript |
|
2024-02-29 16:19 |
|
Publish the Manuscript Online |
|
2024-03-12 10:04 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dong-Qin Xia, Yong Zhou, Shuang Yang, Fang-Fei Li, Li-Ya Tian, Yan-Hua Li, Hai-Yan Xu, Cai-Zhi Xiao and Wei Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Chongqing, China |
cstc2021jcyj-msxmX0501 |
| Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau) |
2022QNXM074 |
|
| Corresponding Author |
Wei Wang, MD, PhD, Professor, Oncology Treatment Center of Traditional Chinese Medicine, Chongqing University Cancer Hospital, No. 181 Hanyu Road, Chongqing 400030, China. zuiailicip@126.com |
| Key Words |
Pancreatic ductal adenocarcinoma; Carbohydrate antigen 19-9; Tumor size; Pathologic response; Biomarkers |
| Core Tip |
Our study demonstrated that post-neoadjuvant therapy (NAT) serum carbohydrate antigen 19-9 (CA19-9) level/pre-NAT serum CA19-9 level and post-NAT tumor size/pre-NAT tumor size were independent factors associated with overall survival for patients receiving NAT and subsequently surgical resection for pancreatic ductal adenocarcinoma. |
| Publish Date |
2024-03-12 10:04 |
| Citation |
Xia DQ, Zhou Y, Yang S, Li FF, Tian LY, Li YH, Xu HY, Xiao CZ, Wang W. Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma. World J Gastrointest Oncol 2024; 16(3): 798-809 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i3/798.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i3.798 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
